- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Genital Pain.
Displaying page 1 of 2.
EudraCT Number: 2019-001572-11 | Sponsor Protocol Number: LLB-2019-01 | Start Date*: 2020-08-05 | |||||||||||||||||||||
Sponsor Name:LABO’LIFE Belgium sprl | |||||||||||||||||||||||
Full Title: Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections. | |||||||||||||||||||||||
Medical condition: Patients presenting recurrent genital herpes infections (4 or more episodes within the 12-months’ period prior to their study entry). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004116-19 | Sponsor Protocol Number: APGELP | Start Date*: 2019-04-08 |
Sponsor Name:Oslo University Hospital | ||
Full Title: The AP-GELP Study: A randomized, placebo-controlled clinical trial on the effects of phosphodiesterase 4-inhibitor apremilast in female genital erosive lichen planus | ||
Medical condition: Genital erosive lichen planus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001705-26 | Sponsor Protocol Number: CYD-GER-0401 | Start Date*: 2005-09-21 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult... | ||
Medical condition: Genito-anal herpes simplex infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002108-25 | Sponsor Protocol Number: CC-10004-BCT-002 | Start Date*: 2015-06-17 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY, FOLLOWED BY AN ACTIVE-TREATMENT PHASE TO EVALUATE THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) IN THE... | |||||||||||||
Medical condition: SUBJECTS WITH ACTIVE BEHÇET’S DISEASE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021556-25 | Sponsor Protocol Number: IBSA 01-2010 | Start Date*: 2011-02-24 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial ... | |||||||||||||
Medical condition: Interstitial Cystitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003675-35 | Sponsor Protocol Number: WV2018 | Start Date*: 2018-11-01 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Efficacy of Very Early Medical Abortion – a randomized controlled non-inferiority trial | ||
Medical condition: Unwanted pregnancy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) FI (Ongoing) AT (Ongoing) DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002190-37 | Sponsor Protocol Number: P140302 | Start Date*: 2015-10-30 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in patients with Behçet disease : STELABEC | |||||||||||||
Medical condition: Behçet disease STELABEC-1: patients with oral ulcers STELABEC-2 : patients with active posterior uveitis or panuveitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002787-27 | Sponsor Protocol Number: 20190530 | Start Date*: 2021-03-15 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From ... | |||||||||||||
Medical condition: Subjects with active Behçet’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) NL (Ongoing) GR (Trial now transitioned) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001443-52 | Sponsor Protocol Number: LLB-2019-02 | Start Date*: 2019-11-13 | ||||||||||||||||||||||||||
Sponsor Name:LABO'LIFE Belgium sprl | ||||||||||||||||||||||||||||
Full Title: Randomized study to evaluate 2LVERU® JUNIOR and 2LVERU® efficacy on the treatment of warts. Protocol EVAsION | ||||||||||||||||||||||||||||
Medical condition: Non genital warts infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004630-38 | Sponsor Protocol Number: HydroceleAlkScler | Start Date*: 2021-05-20 | ||||||||||||||||
Sponsor Name:Region Jämtland/Härjedalen | ||||||||||||||||||
Full Title: Sclerotherapy for hydro and spermatoceles with 99.5% Ethanol, an open clinical multicenter dose escalation study, phase 2 | ||||||||||||||||||
Medical condition: Hydrocele and Spermatocele | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002217-34 | Sponsor Protocol Number: FITO-01/21 | Start Date*: 2022-07-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI | |||||||||||||
Full Title: Tuscany project to investigate on efficacy and safety of Cannabis phytotherapic preparations for the treatment of Aromatase iNhibitor-induced chronic resistaNt pAin in Breast cancer patIents: a pro... | |||||||||||||
Medical condition: Aromatase iNhibitor-induced chronic resistaNt pAin in Breast cancer patIents | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000712-59 | Sponsor Protocol Number: APHP200073 | Start Date*: 2023-03-14 | |||||||||||
Sponsor Name:Assistance Publique - Hôpitaux Paris (Direction de la Recherche Clinique et de l’Innovation) | |||||||||||||
Full Title: Severe erythema multiforme: A randomized controlled trial comparing a short systemic corticosteroids regimen to placebo in the acute established phase | |||||||||||||
Medical condition: Erythema multiforme (EM) in its severe form managed at the hospital | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001602-24 | Sponsor Protocol Number: Th.B-1(2007):BTX(CP/CPPS) | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen | |||||||||||||
Full Title: Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) | |||||||||||||
Medical condition: chronic prostatitis / chronic pelvic pain syndrom | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023254-36 | Sponsor Protocol Number: GUMPID002 | Start Date*: 2011-06-22 | |||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||
Full Title: Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)? | |||||||||||||
Medical condition: Pelvic Inflammatory Disease (PID) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003952-63 | Sponsor Protocol Number: LIQUENIA | Start Date*: 2017-07-07 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria La Fe | |||||||||||||
Full Title: Pilot study of vulval lichen sclerosus treatment by adipose tissue associated with autologous platelet-rich plasma | |||||||||||||
Medical condition: Vulval lichen sclerosus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002945-41 | Sponsor Protocol Number: 78464317 | Start Date*: 2020-09-24 | ||||||||||||||||||||||||||
Sponsor Name:Lone Nikolajsen | ||||||||||||||||||||||||||||
Full Title: The use of intraoperative methadone in children undergoing open urological surgery | ||||||||||||||||||||||||||||
Medical condition: Postoperative pain in children undergoing open urological surgery | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004581-16 | Sponsor Protocol Number: V501-030 | Start Date*: 2015-04-02 |
Sponsor Name:Merck Sharp & Dohme (China) Ltd. | ||
Full Title: An Immunogenicity and Safety Study of GARDASIL™ in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years | ||
Medical condition: Prevention of HPV types 6, 11, 16 and 18 related cervical cancer, vulvar, vaginal pre-cancers, low-grade, pre-cancerous lesions, and genital warts in Chinese female subjects aged 9 to 45 years and ... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-003343-74 | Sponsor Protocol Number: PDS234 | Start Date*: 2007-10-30 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit me... | |||||||||||||
Medical condition: hypoactive sexual desire disorder in women (HSDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004703-14 | Sponsor Protocol Number: ACT16404 | Start Date*: 2021-05-12 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, proof of concept study assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with moderate to severe subacute or discoid/chr... | |||||||||||||
Medical condition: Cutaneous Lupus Erythematosus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004916-21 | Sponsor Protocol Number: EROS | Start Date*: 2019-07-02 | |||||||||||
Sponsor Name:Karolinska Institute | |||||||||||||
Full Title: Early intervention and recovery of sexual function in men and women after treatment of rectal cancer–a randomized controlled study with tadalafil compared to standard care | |||||||||||||
Medical condition: sexual/ erectile function in women and men after treatment for rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.